Rohit Loomba, MD, a professor of medicine in the gastroenterology division at UC San Diego, is the leader of the NAFLD Research Center.
“In pharmacology, molecular medicine, physician training, clinical trial design and drug development, scientists and researchers here have been working on NALFD and related diseases for a long time. But this is a major step. It creates a single entity able to address every aspect of a global disease that didn’t even exist 35 years ago,” said Dr. Loomba.
More articles on gastroenterology:
FDA clears 3 GI/endoscopy devices in January
PQRS deadline extended: 3 quick points
Innovation in GI: Advances in gastroenterology technology & technique
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
